Novogenia AG (MUN:7V0)
Germany · Delayed Price · Currency is EUR 6.50
-0.10 (-1.52%)
Last updated: Oct 7, 2026, 8:00 AM CET
Novogenia AG Revenue
Novogenia AG had revenue of 12.83M EUR in the quarter ending June 30, 2026, a decrease of -7.08%. This brings the company's revenue in the last twelve months to 52.35M. In the year 2025, Novogenia AG had annual revenue of 54.30M with 114.69% growth. That makes Novogenia AG the 26,736th largest company in the world by revenue and 412th in Germany.
Revenue (ttm)
52.35M
Revenue Growth
+114.69%
P/S Ratio
1.65
Revenue / Employee
256.61K
Employees
204
Market Cap
78.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 54.30M | 29.01M | 114.69% |
| Dec 31, 2024 | 25.29M | 7.12M | 39.21% |
| Dec 31, 2023 | 18.17M | -192.17M | -91.36% |
| Dec 31, 2022 | 210.34M | 77.27M | 58.07% |
| Dec 31, 2021 | 133.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Biotest GmbH & Co. KGaA | 648.90M |
| Paion AG | 14.81M |
| MagForce AG | 1.08M |
| co.don AG | 22.00K |
| Biomark Diagnostics | 17.14K |
| bioXXmed AG | -269.00 |
| 2invest AG | -1.64M |